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Abstract 
Banana fruit allergy is well known, but neither immunoglobulin E recognition 
patterns to purified plant food allergens ñor true prevalences of putative banana 
allergens have been established. This study aimed to characterize b-1,3-glucanase 
and thaumatin-like protein (TLP) as banana allergens, testing them, together with 
other plant food allergens, in 51 children with allergic reactions after banana inges-
tión and both positive specific IgE and skin prick test (SPT) to banana. Banana 
b-1,3-glucanase and TLP were isolated and characterized. Both banana allergens, 
together with kiwifruit TLP Act d 2, avocado class I chitinase Pers a 1, palm pollen 
profilin Pho d 2 and peach fruit lipid transfer protein (LTP) Pru p 3, were tested by 
in vitro and in vivo assays. Banana b-1,3-glucanase (Mus a 5) was glycosylated, 
whereas banana TLP (Mus a 4) was not, in contrast with its homologous kiwi aller-
gen Act d 2. Specific IgE to both banana allergens, as well as to peach Pru p 3, was 
found in over 70% of sera from banana-allergic children, and Mus a 4 and Pru p 3 
provoked positive SPT responses in 6 of the 12 tested patients, whereas Mus a 5 in 
only one of them. Both peptidic epitopes and cross-reactive carbohydrate determi-
nants were involved in the IgE-binding to Mus a 5, whereas cross-reactivity between 
Mus a 4 and Act d 2 was only based on common IgE protein epitopes. Profilin Pho 
d 2 elicited a relevant proportion of positive responses on in vitro (41%) and in vivo 
(58%) tests. Therefore, Mus a 4 and LTP behave as major banana allergens in the 
study population, and profilin seems to be also a relevant allergen. Mus a 5 is an 
equivocal allergenic protein, showing high IgE-binding to its attached complex 
glycan, and low in vivo potency. 
Allergy to banana (Musa acuminata) fruit is well established 
in the adult population worldwide, mainly in pollen-sensitized 
patients (1-3) and/or associated with látex allergy in the so 
called 'latex-fruit syndrome' (4, 5). Besides, banana-allergic 
subjects, sensitized to neither látex ñor to pollen have been 
also described (2). In contrast, reported cases of allergic reac-
tions to banana among children are scarce (6-8), in spite of 
this fruit being often introduced in the early infant diet, 
which may lead to an increase number of symptomatic cases 
in the infant population. 
Only two banana allergens appeared in the List of Aller-
gens of the IUIS Allergen Nomenclature Sub-Committee 
before the current study had been carried out. Mus a 1 is a 
14 kDa profilin showing an IgE-binding prevalence of 44% 
in 16 sera with suspected banana allergy and a high cross-
reactivity with its homologous allergens from other plant 
foods, látex and pollens (1). Mus a 2 corresponds to a 
33 kDa class I chitinase harboring a hevein-like N-terminal 
domain, and represents a major banana allergen in patients 
suffering latex-fruit syndrome (9, 10). It displays very similar 
structural (i.e. amino acid sequence) and immunological 
properties to Pers a 1, its homologous class I chitinase and 
allergen from avocado fruit (10, 11). Currently, three addi-
tional banana allergens have increased the list: Mus a 3.0101, 
a non-specific lipid transfer protein (LTP), and Mus a 4.0101 
and Mus a 5, corresponding to the thaumatin-like protein 
(TLP) and b-1,3-glucanase, respectively, that are here 
reported. 
Besides Mus a 1 and Mus a 2, two additional banana fruit 
proteins ) b-1,3-glucanase and thaumatin-like ), have been 
claimed to be potential allergens, but no clinical data support 
this assumption at present. Banana endo-b-1,3-glucanase is a 
33 kDa pathogenesis-related (PR) protein belonging to the 
PR-2 plant protein family (12), whose putative role in the 
latex-fruit syndrome has been suggested, but not clearly dem-
onstrated (13). The PR-2 family also comprises well-known 
allergens from rubber látex, Hev b 2 (14), and olive pollen, 
Ole e 9 (15). Both are N-glycosylated glucanases (15, 16), 
which have been proposed to be involved in látex- and/or 
pollen-plant food cross-reactivity (16-18), and behave com-
monly as minor allergens, although sensitizaron to Ole e 9 
significantly increases in geographical áreas where olive 
pollen exposure is high (19). 
Banana 21 kDa TLP is the second PR protein (PR-5 fam-
ily) targeted as potential allergen (20). Homologous allergenic 
proteins have been described in plant foods and pollens (21). 
Thus, Act d 2 from kiwifruit (22), a food related to látex and 
banana allergy, has been recently identified as a major aller-
gen in Spanish adults with kiwifruit allergy (23). Interest-
ingly, Act d 2, as well as the apple thaumatin-like allergen 
Mal d 2, are glycoproteins with complex asparagine-linked 
glycans (22-24). 
Banana b-1,3-glucanase and TLP have been isolated from 
fruit pulp in the current study, and their in vitro IgE-binding 
capacity and in vivo reactivity explored in a large number of 
pediatric patients sensitized to banana. Four additional rele-
vant plant food allergens have also been tested for compo-
nent-resolved diagnosis of banana allergy: kiwifruit Act d 2 
to evalúate cross-reactivity with banana TLP, avocado Pers a 
1 as representative class I chitinase involved in the latex-fruit 
syndrome, natural date palm pollen Pho d 2 as a proper mar-
ker of profilin sensitizaron (25), and peach fruit Pru p 3 as 
LTP allergen model and most clinically relevant food allergen 
in the Mediterranean área (26). 
Methods 
Patients and sera 
Fifty-one children with allergy to banana fruit were selected 
in the Servicio de Alergia, Hospital Infantil La Paz (Madrid, 
Spain), based on (i) a clinical history indicating allergic reac-
tions (oral allergy syndrome, urticaria, vomiting, angioedema 
or anaphylaxis) after ingestión of banana fruit; (¡i) a positive 
prick to prick test to the fresh fruit; and (i¡¡) specific IgE lev-
éis to banana >0.35 kU/l , as determined by the CAP system 
FEIA (Phadia, Uppsala, Sweden). Demographic and clinical 
data of the selected patients are summarized in Table l . 
None of these children but one (no. 27, Table 1) had allergic 
symptoms (urticaria) upon contact with látex products. 
A subgroup of 12 patients (nos. 40-51 in Tablel) were 
subjected to a skin prick test (SPT) with the purified allergens 
in a second study phase. 
Written informed consents were obtained from parents of 
all patients, and the study was approved by the Ethical Com-
mittee of Hospital La Paz (Madrid). 
Individual sera from all selected children were assayed for 
specific IgE determination and a serum pool (n = 36, nos. 
1-36 in Table 1) in IgE immunodetection assays. In addition, 
six individual sera (nos. 2, 8, 24, 32, 38 and 43 in Table 1) 
were used in ELISA inhibition assays. 
Preparation of banana fruit extract 
A homemade banana extract was prepared following the 
method described by Anliker et al. (27). Briefly, peeled fruits 
were cut into pieces, ground in a mortar under liquid nitro-
gen, and then added to prechilled 4-hydroxy-4-methyl-2-pen-
tanone ()20»C; 1:3 w/v), homogenized, and then chilled 
acetone ()20»C; 1:4 w/v) was added to the suspensión, and 
homogenized again. The suspensión was maintained over-
night at ) 20»C, then filtrated over a suction filter, and the 
power obtained washed with chilled acetone and acetone-
diethyl ether (1:1 v/v; )20»C). The filter residue was freeze 
dried, extracted with PBS buffer (100 mm potassium phos-
phate, 150 mm NaCI, pH 7.4; 1:10 w/v, 1 h, 4-C), and centri-
fuged (12,100 g, 30 min, 4»C). The supernatant was dialysed 
(cut-off point 3.5 kDa) against H20, freeze dried, and its pro-
tein concentration quantified according to the method of 
Bradford (28). 
Purification and characterization of allergens 
The banana extract was subjected to anion-exchange chroma-
tography on a Waters Accell Plus QMA cartridge (Waters, 
Milford, MA, USA), equilibrated with 20 mm l-histidine (pH 
5.0) buffer, and eluted with 0.5 m NaCI in the same buffer. 
The non-retained material was dialysed (cut-off point 
3.5 kDa) against H20, freeze dried, and then fractionated by 
cation-exchange chromatography on a Bio-Scale Mini 
Macro-Pep High S column (Bio-Rad, Hercules, CA, USA). 
The column was equilibrated with 20 mm formic acid (pH 
4.0) buffer, eluted with a linear salt gradient to 0.5 m NaCI 
in the same buffer (0-0.5 m in 140 min; 0.5 ml/min), and 
eluted fractions were dialysed (cut-off point 3.5 kDa) against 
H20, freeze dried, and checked by SDS-PAGE fractionation 
and immunodetection with a serum pool from banana-aller-
gic patients to detect banana b-1,3-glucanase and TLP. Pers 
a 1, the major allergen and class I chitinase from avocado 
fruit, was isolated by a method previously described (29). Act 
d 2, the thaumatin-like allergen from kiwifruit, was purified 
as described by Palacin et al. (23), and natural (n) and 
recombinant (r) Pru p 3, the LTP allergen from peach fruit, 
as reported by Diaz-Perales et al. (30). Pho d 2, the natural 
profilin from date palm pollen, was supplied by ALK-Abello 
(Madrid, Spain). All four isolated allergens, as well as 
banana b-1,3-glucanase and TLP, were quantified using a 
commercial bicinchoninic acid test (Pierce, Cheshire, UK). 
Identity and purity of allergens were ascertained by the 
following methods: (i) SDS-PAGE on Bio-Rad Miniprotean 
III System (Bio-Rad) gels (15% polyacrylamide) under reduc-
ing conditions (31); and (¡i) N-terminal amino acid sequenc-
ing using standard methods and an Applied Biosystem 
Precise 494 gas-phase sequencer (Foster City, CA, USA). 
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Table 1 (Continued) 
Patient No 
50 
51 
Age 
(yr)/ 
gender* 
1.25/M 
12/M 
Symptoms 
to banana-
U 
0 
Total 
igE 
(kU/l) 
112 
1746 
Specific 
IgEto 
banana 
(kU/l) 
2.4 
16.0 
Allergy to 
other plant 
foods-
No 
pe 
Allergy to 
pollen§ 
No 
gr, ol, cu 
Specifh 
Glu 
0.46 
; IgE 
TLP 
0.47 
0.25 
[ELISA) to 
Act 
0.41 
0.28 
purified 
Pers 
0.32 
0.27 
allergen 
Pru 
0.50 
0.73 
s-
Pho 
0.45 
0.31 
Bro 
0.39 
0.32 
*F, female; M, male. 
•U, urticaria; O, oral allergy syndrome; V, vomiting; A, anaphylaxis; An, angiodema; R, rejection; L, lip edema. 
•Kw, kiwi; pi, pineapple; to, tomato; me, melón; ha, hazeinut; pe, peach; pn, peanut; ap, apple; wa, walnut; le, lentil; or, orange; pr, pear; It, 
lettuce; pl, plum. 
§gr, grass; ol, olive; cu, Cupressus; lo, Lolium. 
-Valúes (OD units) >0.24 OD units were considered positive (see Methods). Gluc, banana b-1,3-glucanase; TLP, banana thaumatin-like 
protein; Act, kiwifmit thaumatin-like protein Act d 2; Pers, avocado class I chitinase Pers a 1; Pru, peach lipid transfer protein Pru p 3; Pho, 
palm pollen profilin Pho d 2; Bro, pineapple bromelain (marker of plant complex glycans). 
Immunodetection assays 
Banana extract (20 Ig of protein) and isolated allergens 
(3 Ig) were fractionated by SDS-PAGE, electrotransferred 
onto polyvinylidene difluoride membranes and IgE immuno-
detected essentially as previously described (23). A serum 
pool (n = 36; nos. 1-36 in Table 1) from banana-allergic 
patients (1:20 dilution) and goat anti-human IgE-peroxidase 
conjúgate (Biosource, Camarillo, CA, USA; 1:3000 dilution) 
were used, and IgE-binding components detected by means 
of chemiluminiscence (Amersham Biosciences, Little Chal-
font, UK). A pool of sera (n = 10) from patients with dust 
imite, but not plant food or pollen allergy, was assayed as 
negative control. 
Alternatively, blocked membranes were immunodetected 
with rabbit polyclonal antibodies to plant complex 
asparagine-linked glycans (32) (1:10,000 dilution), and then 
treated with goat anti-rabbit IgG-peroxidase conjúgate 
(Dako, Carpintería, CA, USA; 1:10,000 dilution) and 
revealed by means of chemiluminiscence (Amersham Bio-
sciences). 
Specific IgE determination and ELISA-inhibition assays 
Individual sera (1:15 dilution) from banana-allergic patients 
were tested by a direct ELISA assay previously reported (23) 
to determine specific IgE to banana extract (20 Ig/ml in solid 
phase) and purified natural banana b-1,3-glucanase and TLP, 
nAct d 2, nPers a 1, nPho d 2, rPru p 3 and commercial bro-
melain (Sigma, St Louis, MO, USA) (3 Ig/ml each in solid 
phase). Blocking solution (Sigma) without solid phase [n = 
69; mean (OD units) ± s.d. = 0.09 ± 0.05], and a serum 
pool (n = 10) from patients allergic to dust imite, but not to 
plant food or pollen [n = 10; means (OD) ± s.d. to banana 
extract = 0.08 ± 0.02, to banana b-1,3-glucanase = 0.11 ± 
0.04, to banana TLP = 0.05 ± 0.06, to Act d 
2 = 0.09 ± 0.04, to Pers a 1 = 0.13 ± 0.03, to Pho d 
2 = 0.09 ± 0.04 and to Pru p 3 = 0.06 ± 0.06] were tested 
as negative controls. Specific IgE levéis >0.24 OD units were 
considered to be positive (highest valué of mean + 3 • s.d. 
of negative controls). All tests were carried out in triplícate. 
ELISA-inhibition assays were performed by the same 
method, except that the sera were previously incubated 
(3 h, 25»C) with the appropriate inhibitor. Different puri-
fied allergens were tested as solid phase (3 Ig/ml) and/or 
inhibitors (3 and 6 Ig/ml). All assays were carried out in 
triplícate. 
Skin prick tests 
SPTs with banana extract (2 mg of protein/ml) and purified 
banana b-1,3-glucanase, TLP, nAct d 2, nPers a 1 and nPho 
d 2 (50 Ig/ml), and nPru p 3 (20 Ig/ml) in a 1:1 (v/v) PBS 
buffer/glycerol solution, were performed according to stan-
dard procedures (33). Histamine dihydrochloride (10 mg/ml) 
and PBS buffer/glycerol solution served as positive and nega-
tive controls, respectively. A mean wheal diameter of 3 mm 
or larger (15 min after puncture) than that produced by the 
negative control was considered a positive response. Three 
healthy subjects were tested with all samples as a control 
group. Duplícate of each sample were assayed in patients and 
control subjects. 
Statistics 
Correlation between specific IgE levéis to the different aller-
gens tested was determined by one-way intraclass correlation 
coefficient (ICC), performed at a significant level of 
p < 0.05. Tests were carried out using the spss statistical 
software versión 12 for Windows (SPSS Inc., Chicago, IL, 
USA). 
Results 
Clinical characteristics of selected patients 
All 51 selected patients were children (mean age: 5.3 yr; range 
0.5-14 yr; 18 girls /33 boys) showing adverse reactions after 
kDa Coomjissic Serum pool Anli-CCD 
Bn I 
Figure 1 Protein staining (Coomassie) and ¡mmunodetection with 
IgE of a serum pool from banana-allergic patients (Serum pool) or 
rabbit polyclonal antibodies to plant complex glycans [Anti-cross-
reactive carbohydrate determinant (CCD)] of the following samples 
separated by SDS-PAGE: banana fruit extract (Bn), banana b-1,3-
glucanase (1), banana thaumatin-like protein (2), avocado class I 
chitinase Pers a 1 (3), kiwifruit thaumatin-like protein Act d 2 (4), 
palm pollen profilin Pho d 2 (5) and peach lipid transfer protein Pru 
p 3 (6). Bromelain (+) and bovine serum albumin ()) were used in 
panel Anti-CCD as positive and negative control, respectively. 
banana ingestión and specific IgE to this fruit (Table 1). Oral 
allergy syndrome was found in 53% of subjects, and systemic 
reactions (mainly urticaria and vomiting), including anaphy-
laxis (n = 3) in 47% of them. 
Most patients (86%) had also allergic symptoms to other 
plant fruits and nuts (Table 1), kiwi (35%), peanut (29%), 
hazelnut (27%), peach (27%) and melón (20%), being the 
most frequent. Furthermore, up to 65% of the selected chil-
dren were also allergic to pollen, but almost exclusively to 
grass (91%), olive (82%) and/or Cupressus (61%) pollen 
(Table 1). 
Isolation and characterization of putative banana allergens 
Two abundant proteins in the banana pulp extract (Fig. 1 
Coomassie, lañe Bn), namely b-1,3-glucanase (Gluc) and 
TLP, previously proposed as putative allergens (12, 20), were 
isolated from this extract by a two-step chromatographic pro-
cedure (not shown). Purity of each obtained allergen was 
ascertained by the presence of a single protein band of the 
expected apparent molecular weight after SDS-PAGE separa-
ron (Fig. 1 Coomassie, lañes 1 and 2), and a single deter-
mined N-terminal amino acid sequence (up to 27 residues for 
each protein, Fig. 2). 
Gluc, the purified 30 kDa protein, showed a N-terminal 
amino acid sequence (27 residues) ¡dentical to that of Unigen 
accession gl 83754908 (mature protein; Fig. 2a), which corre-
sponds to the banana endo- b-1,3-glucanase whose crystal 
structure was reported by Receveur-Brechot et al. (12). Gluc 
was glycosylated (Fig. 1 Anti-CCD), as indicated by its 
recognition by anti-complex asparagine-linked glycans anti-
bodies. 
Regarding TLP, the isolated 20 kDa putative allergen, its 
first 28 N-terminal residues fully matched the corresponding 
ones of the Unigen accession gl 88191901 amino acid 
sequence (mature protein; Fig. 2b), which encodes the 
banana TLP whose 3D-structure was resolved by Leone et 
al. (20). Interestingly, TLP was not glycosylated by attach-
ment of N-linked complex glycans (Fig. 1 Anti-CCD), in 
contrast with its kiwi homologous allergen Act d 2, which 
presented the two glycosylated forms previously described 
(23). 
Specific IgE to banana Gluc and TLP and to other represen-
tative plant food allergens 
Both purified banana Gluc and TLP, as well as avocado Pers 
a 1, kiwifruit Act d 2, palm pollen Pho d 2 and peach Pru p 
3, were recognized by a serum pool (n = 36) from banana 
allergic patients in IgE ¡mmunodetection assays (Fig. 1 
Serum pool). Aggregates with strong IgE-binding capacity 
were detected in Pers a 1, in line with results previously 
reported (11). A pool of sera tested as negative control (see 
Methods) recognized neither purified allergen ñor band in the 
banana extract (not shown). 
The potential relevance of Glu and TLP as banana aller-
gens was suggested by the high number of sera showing spe-
cific IgE to each purified protein. Thus, 84% and 72% of the 
51 sera from banana-allergic patients showed specific IgE to 
Gluc and TLP, respectively (Table 1 and Fig. 3). On the 
other hand, a high prevalence (over 75% of sera with specific 
IgE to) was also found for peach Pru p 3 and pineapple bro-
melain (marker of cross-reactive carbohydrate determinants, 
CCDs), and (over 50%) for kiwifruit Act d 2, whereas avo-
cado Pers a 1 and profilin Pho d 2 reached valúes under 50% 
(Table 1 and Fig. 3). 
Both B-cell peptidic epitopes and cross-reactive carbohydrate 
determinants are involved in the IgE-binding to banana Gluc 
The glycosylation of Gluc led to evalúate the role of CCDs 
in its IgE-binding capacity. Therefore, individual sera dis-
playing two different specific IgE profiles to Gluc and brome-
lain were analyzed by ELISA-inhibition assays (Fig. 4a,b). 
Sera from patients monosensitized to Gluc (only two; see 
Table 1) indicated the presence of IgE epitopes linked to the 
protein structure and non-sensitive to CCDs, whereas those 
from subjects polisensitized to Gluc, Act d 2 and bromelain 
(a) 
A l l e r g e n 
Banana g lucanase 
Látex Hev b 2 
O l ive Ole a 9 
Amino acid seqaence 
- — IGVCÍ<aiLaiK]^PPSE^nreLyKSNNIA3Ma,YDPMaAaLQftLRNSNIQVLI. DVIRS 
--QVGVCYGM!jaiHLPPVSEVIALYKKSNIT31ÍHIYDPMaAVLEALaGSHISLILGVPNS 
CSFIfiVNyGOjLSDNLPSI^TWIiKCTTIQ^TpiPGRiPAVIKAEAfirGVilVIGFDNG 
Banana g l u c a n a s e 
L á t e x Hev b 2 
O l i v e O l e e 9 
DV2SlASNPSAaCEHlRaKWAVWPSVSFRYIAVClGLIPGSD LAQYILPAMP.NIY 
DI^SIJ-HPSH3KSWVQKKV^CT>SSvLFRYIAVGffiISPVl&GT»IIAQFVLPAMaHIH 
D IPTIASNPNVASÍ^VKSNVHSTVPASHIIAITVGIEVLTSGD^—LISQLLPAaaHVQ 
Banana g l u c a n a s e NALSSAGI^NQIKVETAVDTSULCTSYPPSAGftFSSAA(JAYLSPIVBFLASMGAPLLVNV 
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O l i v e O l e e 9 NALKAASLGGKVKVETVHAMAVLSQSYPPSSGVIHPGLGDIMKALLÍÍFQSAMDAPFMISP 
Banana g l u c a n a s e 
L á t e x Hev b 2 
O l i v e O l e e 9 
Y PY FSYTGNPGQISLP YALFTAS GVWQDGR-FSY(ja. FDArVDAVFAALERVGGANVAV 
Y PY FTY A YHPH DI SLP YALFT SP SVWW DGQ-RGY KHL FDATL DA LY SALZKASG GS LE V 
Y PY FAY KNO.PT FDTLA FCLFQFN AG ^ T J S G M O Í KY TMÍ FDACy DA VH SALHAMGF K¿> IEI 
Banana g l u c a n a s e WSESGWPSAGG—GAEASTSNAÍtrYNQNLIHHVGG— GTP5P.PGKSISAYIFSMÍNSNS 
L á t e x Hev b 2 WSESGWPSAG AFAATFDMGKEYLSKLI(ÍIVKG—GTPKRPHSAISTYLFiMIDENK 
O l i v e O l e e 9 WAEXGrJEHGC-DStEVGPSLDNAíaWGNLINHLKSflVGTPLMPGKSrDTYLFSLYDiDK 
B a n a n a g l u c a n a s e 
L á t e x Hev b 2 
O l i v e O l e e 9 
KAGG-ISQNEGLFYPN KQPVYQISF 
KQPE-VEKHBGLFFPNKWQKYNLNFSA 
KIG ASS SKYPGLFKPOGSTTYDVGLLK 
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(b) 
Allergen Amino acid seqaence 
Banana TLP ATFEIVNRCSYTVVffiAAVPGGGR pLNeGSSWTINVNAGTTGGaiWGaTGCSF 
K i w i f r u i t A c t d 2 ATFNIINNCPFTVWAAAVPCGGK HLERG^tWIIHPGAGTKGAHVHPaTCCHF 
C u p r e s s us Cup 3 3 VKFDIKNQCPYTVHAAGLPGGQÍ PXr£Q2rWTVNLAAGTASAaFHGRTGCTF 
A p p l e Mal d 2 AKITFTNHCPNTVWPGTLTGI^P8LSLTGFSLASKASRSVnAPS-PWSGaFHGP-TRCST 
Banana TLP DGSGP£RC8TGIKG^VLSCn-AY3IPP-NTIJ£FAl^FmrLDFFDISLVI>GFIJVPMDFS 
K i w i f r u i t A c t d 2 DfflGMKCQTGKH^IXO^Í^GCPP-KTIJSYALMJFMHLDFFDISLVDGFHVÍMEFS 
C u p r e s s u s Cup 3 3 DASGKGSCP.SGECG-G2LSCTVSGAVP-ATLAZYTQ SDQDYYDVSLVDGFHIPLAIN 
A p p l e Mal d 2 OAAGKFTCETArcGSGSVACHGñGAVPPATLVErTIAAHGGCPYYDVSLVDGFHLPMSVA 
Banana TLP PT--SGGC-aGI3CñADIKGQCPG--ALKAPGG CNWPCTVyKTDQYCCBSG 
K i w i f r u i t A c t d 2 PT--SGGCTBGIKCXADINGGCPN--SLRAPGG CHNPCTVFKTDCYCCHSG 
C u p r e £ £ u s Cup 3 3 PT--NTKC-TAPACXADINAVCPS--ZLKTOGG CtfSACKVLQrDQYCCRHAY—VD 
A p p l e Mal d 2 PC^GTGEC-roSSCPAHVNKVCPAPI^vKAASGSVISCKSACLAFGDSiíYCCTPPNNTPS 
Banana TLP ACSPTDYSQFFfSHCPDAYSYPKDOCrTTFTCPGGTKYRWFCP 
K i w i f r u i t A c t d 2 NCGLTNFSKFFKDSCPaAYSYPKDOarSTFTCPAGTNYKWFCP 
Cupressus Cup 3 3 NCPATNYSKIFKNCCPÍJAYSYAKCD-TATFACASGTDYSIVTCP 
A p p l e Mal d 2 TCPPTEYSEIFEKQCPÍJAYSYAYDDKNSTFrCSGGPDYVITFCP 
\ I d 
77 
42 
Figure 2 Alignment of full amino acid sequences of (a): banana 
b-1,3-glucanase (accession no. gi 83754908), látex Hev b 2 (acces-
sion no. P52407) and olive pollen Ole e 9 (without its C-terminal 
domain; accession no. Q94G86). (b): banana thaumatin-like protein 
(accession no. gi 88191901), kiwifruit Act d 2 (accession no. 
P81370), Cupressus sempervirens pollen Cup s 3 (accession no. 
Q69C52) and apple Mal d 2 (accession no. Q3BCT4). The N-termi-
nal gray-highlighted sequences were confirmed by protein sequenc-
¡ng of the isolated allergens. Sequence identities to banana b-1,3-
glucanase or thaumatin-like protein (% Id) are indicated on the right 
side. Potential N-glycosylation sites are marked (bold letters) in 
panel b. 
(25 patients; see Table 1) showed major IgE-binding to plant 
complex glycans. 
In contrast, similar ELISA-inhibition assays (Fig. 4c) sup-
ported that cross-reactivity between non-glycosylated banana 
TLP and its glycosylated kiwifruit homologous Act d 2 was 
only based on IgE peptidic epitopes. A strong correlation 
( ICC = 0.760; p < 0.0001) of specific IgE levéis to banana 
TLP and Act d 2 was found in the population (n = 51) study. 
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Bn Gluc TLP Act Pers Pru Pho Bro 
PositivelgE n 51 43 37 30 15 40 21 41 
% 100 84 72 59 29 78 41 80 
Mean(n = 51)IgElevel 0.52 0.44 0.44 0.36 0.24 0.57 0.32 0.45 
(O.D. units) 
Figure 3 Sensitization to banana potential allergens and other plant 
food allergens of pediatric banana-allergic patients (n = 51). Valúes 
(mean; n = 3) are specific IgE levéis (OD units) to banana fruit 
extract (Bn) and purified allergen banana b-1,3-glucanase (Gluc) and 
thaumatin-like protein (TLP), kiwifruit thaumatin-like protein Act d 2 
(Act), avocado class I chitinase Pers a 1 (Pers), peach lipid transfer 
protein Pru p 3 (Pru), palm pollen profilin Pho d 2 (Pho) and pineap-
ple bromelain (Bro; marker of plant complex glycans). Valúes >0.24 
OD units (long horizontal line) were considered positive (see 'Meth-
ods'). Mean valúes for each solid phase were indicated as short 
horizontal lines. 
In vivo reactivity of banana Gluc and TLP and other 
representative plant food allergens 
SPTs with the six purified plant food allergens tested in this 
study were carried out in 12 banana-allergic patients showing 
positive in vivo response to the banana extract. The results 
obtained were compared with those of in vitro specific IgE 
determination (Table 1), and shown in Table 2. Positive SPT 
responses in around 50% of patients were found for banana 
TLP, peach Pru p 3 and palm pollen Pho d 2, roughly in line 
with the corresponding in vitro results. In contrast, under 
20% of subjects responded to the glycosylated allergens 
banana Gluc and kiwifruit Act d 2 whereas specific IgE to 
each of them was found in over 65% of the same subjects. A 
low rate (8% of patients) of positive SPT responses was also 
induced by avocado Pers a 1. 
Discussion 
Banana should be considered a putative important allergenic 
food source, based on its extensive consumption by the adult 
population, early introduction in infant diets, and involve-
ment in allergic disorders, such as the latex-fruit syndrome. 
Particularly, an increasing number of non-reported symptom-
atic cases of infants with banana hypersensitivity have 
seemed to emerge in Spain and other European countries 
(34). However, limited care has been devoted to banana 
allergy and its allergens in the last decade. The aim of this 
work was to assess the relevance of two banana proteins, as 
well as of several representative plant food allergens, as aller-
gens linked to banana hypersensitivity in a selected large 
group of children with allergy to banana. 
The two isolated banana proteins, unambiguously identi-
fied as b-1,3-glucanase (Gluc) and TLP, respectively, seemed 
to be among the most abundant (Fig. 1 Coomassie) and 
strongest IgE-binding (Fig. 1 Serum pool) components of the 
banana extract. Taking into account that both are natural 
allergens, the potential presence of more than one isoform in 
each protein preparation can not be discarded. 
Gluc, recently designated as Mus a 5 by the IUIS Aller-
gen Nomenclature Sub-Committee, harbored cross-reactive 
carbohydrate determinants (CCDs) (35). The CCDs played 
an important role in the IgE-binding capacity of Mus a 5 
(Fig. 4), and partly explained the great difference between 
its in vitro (specific IgE detected in 84% of sera from 
banana-allergic infants) and in vivo (8% of positive SPT 
responses) reactivity. A similar behavior has been described 
for other glycosylated allergens from plant foods, such as 
orange germin-like glycoprotein Cit s 1 (36). However, the 
identification of monosensitized patients to (Table 1, nos. 2 
and 43), and IgE peptidic epitopes (Fig. 4a) of Mus a 5, 
supported its true allergenic potency. Furthermore, 
cross-reactivity with other allergenic plant b-1,3-glucanases 
also N-glycosylated, such as rubber látex Hev b 2 and 
olive pollen Ole e 9 (14-16), a potentially relevant and 
unknown issue in plant foods and pollens co-sensitizations, 
has to consider both CCDs and protein epitopes. In this 
context, the comparison of natural and deglycosylated 
forms of the allergenic b-1,3-glucanases mentioned above 
in different in vitro and SPT assays will clarify the role 
of complex Asn-linked glycans in both IgE-binding and 
cross-reactivity. 
The second isolated banana fruit protein, TLP, named 
Mus a 4.0101 by the IUIS Allergen Nomenclature Sub-
Committee, was not glycosylated, contrary to other aller-
genic TLPs, such as those from kiwi and apple (23, 24). 
Mus a 4 is a major banana allergen in the pediatric popula-
tion herein investigated, as indicated by both its in vitro 
(72% of sera with specific IgE to) and in vivo (50% of posi-
tive SPT responses) reactivity. The relevance of other TLP 
food allergens widely varíes, from major allergens in 
kiwifruit (23) to low reacting in apple (37). Moreover, very 
different prevalences (% of sera with specific IgE) have been 
reported for the same TLP allergen, such as Act d 2 (23, 
38). ELISA-inhibition assays have allowed to detect com-
mon peptidic IgE epitopes in Mus a 4 and Act d 2 (Fig. 4 
c), thus supporting cross-reactivity between TLP allergens 
besides the presence of CCDs. Furthermore, the immuno-
logical closeness between the banana and kiwi allergens 
could partly explain why kiwifruit is the main plant food 
associated with banana in this pediatric study group 
(Table 1). Palacin et al. (39) have recently identified peach 
TLPs as potential major allergen of this fruit in the Spanish 
adult population, thus further supporting the role of TLPs 
as putative panallergens involved in plant food allergy and 
pollen/food co-sensitization. 
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Figure 4 ELISA-inhibition assays using individual sera from 
banana-allergic patients with different specific IgE (slgE) profiles to 
purified banana allergens. Appropriate purified allergens were used 
as solid phase (3 Ig/ml) and/or inhibitors (6 Ig/ml: gray bars, and 
3 Ig/ml: black bars). Serum numbers (no.) correspond to those of 
Table 1. Abbreviations of purified allergens are as in Table 1 and 
Fig. 4. Means (n = 3) and s.d. (narrow bars) are represented. 
Table 2 Skin prick test (SPT) responses to banana extract (Bn) and 
to purified allergens banana b-1,3-glucanase (Gluc) and thaumatin-
like protein (TLP), kiwifruit thaumatin-like protein Act d 2 (Act), avo-
cado class I chitinase Pers a 1 (Pers), peach lipid transfer protein 
Pru p 3 (Pru) and palm pollen profilin Pho d 2 (Pho) ¡n banana-aller-
gic patients (nos 40-51 ¡n Table 1) 
Bn Gluc 
Positive SPT responses-
n = 12 12 
% 100 
Positive slgE-
n = 12 12 
% 100 
1 
8 
10 
83 
TLP 
6 
50 
10 
83 
Act 
2 
17 
8 
67 
Pers 
1 
8 
7 
58 
Pru 
6 
50 
7 
58 
Pho 
7 
58 
8 
67 
Bro* 
nd 
nd 
9 
75 
"Pineapple bromelain (marker of plant complex glycans). nd, not 
determined. 
•Mean weal diameter • 3 mm (see Methods). 
•See Table 1, patients 40-51. 
On the other hand, molecular markers of three impor-
tant allergen families linked to fruit allergy have rendered 
different results. Peach Pru p 3, tested as representative 
member of LTPs, has behaved as a major allergen in the 
group of selected banana-allergic patients. Up to 78% and 
50% of positive specific IgE determinations and SPTs, 
respectively, were obtained. Food allergy related to LTPs, 
particularly peach Pru p 3, is the most frequent plant food 
allergy in Mediterranean adults, peach being the food that 
probably provokes the primary sensitizaron to these aller-
gens in most patients (26, 37, 40, 41). Interestingly, the 
prevalence of sensitizaron to Pru p 3 in pediatric subjects 
has been recently found twice as high as in adults among 
pollen-allergic subjects from Southern and Central Spain, 
although no relationship between sensitizaron to this aller-
gen and any specific pollinosis was found (19). A Pru p 3 
homologous allergen (40% N-terminal amino acid sequence 
identity; 22 residues), named Mus a 3 by the IUIS Allergen 
Nomenclature Sub-Commitee has been detected in banana 
fruit, but the very low levéis of this LTP in the extract 
from banana pulp has prevented its isolation in sufficient 
amount to carry out specific IgE determinations in individ-
ual sera using the purified allergen. The putative prevalence 
of Mus a 3 has been estimated by IgE immunodetection of 
a banana fruit extract with individual sera from banana-
allergic patients (n = 36), showing recognition levéis of the 
putative Mus a 3 - SDS-PAGE band by around 20% of 
the sera tested. However, the low amount of Mus a 3 in 
the banana fruit extract strongly suggests revising this esti-
mated prevalence (R. Sanchez-Monge, personal communica-
tion). On the other hand, no banana reactivity has been 
found in adult LTP-allergic patients from Italy, and this 
fruit has been consequently proposed as a safe food for 
LTP-allergic subjects (42, 43). Thus, cross-reactivity 
between Pru p 3 and Mus a 3, as well as the putative role 
of the latter as primary sensitizer in banana allergy, remain 
to be clarified. 
Profilin sensitizaron, using date palm pollen Pho d 2 as 
proper marker (25), seems also relevant in the group of 
banana-allergic children. Positive responses were found in 
40-50% of the subjects by both ELISA assays and SPTs. 
This prevalence is similar to that observed (44%) testing spe-
cific IgE to recombinant Mus a 1 (banana profilin) in sera 
from Germán adults with birch pollen allergy and allergic 
reactions to banana (1). In contrast, class I chitinases with 
N-terminal hevein-like domain, represented by avocado Pers 
a 1 (11) have shown low specific IgE prevalence (29%) and in 
vivo potency (positive response in 1 out of 12 patients). Mus 
a 2, the banana class I chitinase, has been identified as a 
major allergen in subjects with latex-fruit syndrome (10). 
However, this syndrome is almost absent (only one child was 
allergic to látex) in the pediatric population studied, indicat-
ing that both profiles and, most probably, cross-reactive 
routes of sensitizaron, are different from those in adult 
groups previously studied (9, 10). Nevertheless, future 
research on sensitizaron to látex Hev b 6 in this population 
will help to determine its possible relationship with látex 
allergy. 
In summary, most infants with allergy to banana were sen-
sitized to many allergen families, and, particularly, a high 
proportion to CCDs. Mus a 4 (TLP) and peach LTP Pru p 3 
behave as major allergens, and profilin as a relevant one, in 
the group of patients herein investigated. Mus a 5 (b-1,3-glu-
canase) seems to be an equivocal allergenic protein displaying 
very high specific IgE prevalence, predominantly due to reac-
tivity to CCDs, but shows low in vivo reactivity. 
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